AU2006218743A1 - Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity - Google Patents

Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity Download PDF

Info

Publication number
AU2006218743A1
AU2006218743A1 AU2006218743A AU2006218743A AU2006218743A1 AU 2006218743 A1 AU2006218743 A1 AU 2006218743A1 AU 2006218743 A AU2006218743 A AU 2006218743A AU 2006218743 A AU2006218743 A AU 2006218743A AU 2006218743 A1 AU2006218743 A1 AU 2006218743A1
Authority
AU
Australia
Prior art keywords
substituted
compound
group
alkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006218743A
Other languages
English (en)
Other versions
AU2006218743A8 (en
Inventor
Yu Bai
Daniel Chu
Yaohui Lei
Zhi-Jie Ni
John Jian-Xin Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
North China Pharmaceutical Group
Novartis Vaccines and Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North China Pharmaceutical Group, Novartis Vaccines and Diagnostics Inc filed Critical North China Pharmaceutical Group
Publication of AU2006218743A1 publication Critical patent/AU2006218743A1/en
Publication of AU2006218743A8 publication Critical patent/AU2006218743A8/en
Assigned to NOVARTIS VACCINES AND DIAGNOSTICS INC. reassignment NOVARTIS VACCINES AND DIAGNOSTICS INC. Request for Assignment Assignors: NORTH CHINA PHARMACEUTICAL GROUP CORPORATION, NOVARTIS VACCINES AND DIAGNOSTICS INC.
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2006218743A 2005-02-28 2006-02-27 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity Abandoned AU2006218743A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65763605P 2005-02-28 2005-02-28
US60/657,636 2005-02-28
PCT/US2006/007021 WO2006093933A2 (en) 2005-02-28 2006-02-27 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity

Publications (2)

Publication Number Publication Date
AU2006218743A1 true AU2006218743A1 (en) 2006-09-08
AU2006218743A8 AU2006218743A8 (en) 2008-04-17

Family

ID=36941722

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006218743A Abandoned AU2006218743A1 (en) 2005-02-28 2006-02-27 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity

Country Status (7)

Country Link
US (2) US7368422B2 (enExample)
EP (1) EP1858908A4 (enExample)
JP (2) JP2008531701A (enExample)
AU (1) AU2006218743A1 (enExample)
BR (1) BRPI0607701A2 (enExample)
CA (1) CA2599336A1 (enExample)
WO (1) WO2006093933A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1818340A4 (en) 2004-11-29 2009-02-25 Univ Nagoya Nat Univ Corp ANTIBIOTIC MONOMERS GLYCOPEPTIDE DERIVATIVES
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US20070185015A1 (en) * 2005-02-28 2007-08-09 Chiron Corporation and North China Pharmaceutical Corporation Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
GB2449156B8 (en) * 2007-05-08 2010-06-02 Lead Therapeutics Inc Semi-synthetic glycopeptides with antibacterial activity.
KR20100109936A (ko) * 2007-12-26 2010-10-11 리드 테라퓨틱스, 인크. 항박테리아제로서의 신규한 반(半)-합성 글리코펩티드
WO2010048340A2 (en) * 2008-10-24 2010-04-29 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
WO2011060222A2 (en) * 2009-11-13 2011-05-19 Beckman Coulter, Inc. Systems and methods for detecting the presence of a biological status using clustering

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692327A (en) * 1984-09-06 1987-09-08 Fujimori Kogyo Co., Inc. Laminated film for packaging
US5500410A (en) * 1989-03-29 1996-03-19 Gruppo Lepetit S.P.A. Substituted alkylamide derivatives of teicoplanin
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5488131A (en) * 1994-03-23 1996-01-30 California Institute Of Technology Synthesis of compounds with predetermined chirality
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
BRPI9914221B8 (pt) * 1998-12-23 2021-05-25 Advanced Medicine Inc derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
US6699836B2 (en) * 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
US6498238B1 (en) * 1999-05-19 2002-12-24 Princeton University Glycopeptide antibacterial compounds, compositions containing same and methods of using same
US20030008812A1 (en) * 2001-02-02 2003-01-09 Christensen Burton G. Glycopeptide derivatives
US7348309B2 (en) * 2001-03-30 2008-03-25 Wisconsin Alumni Research Foundation Glycorandomization and production of novel vancomycin analogs
KR20060091049A (ko) 2002-08-30 2006-08-17 케이.유.루벤 리서치 앤드 디벨럽먼트 글리코펩티드 항생제 및 그것의 반합성 유도체 및 항바이러스제로서의 그것의 사용
AU2003287605A1 (en) * 2002-11-12 2004-06-03 Enzon Pharmaceuticals, Inc. Polymeric prodrugs of vancomycin
US7521418B2 (en) * 2003-05-27 2009-04-21 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity

Also Published As

Publication number Publication date
WO2006093933A3 (en) 2007-03-08
JP2009102445A (ja) 2009-05-14
US20070021328A1 (en) 2007-01-25
CA2599336A1 (en) 2006-09-08
AU2006218743A8 (en) 2008-04-17
BRPI0607701A2 (pt) 2009-11-03
US20080214444A1 (en) 2008-09-04
JP2008531701A (ja) 2008-08-14
WO2006093933A2 (en) 2006-09-08
EP1858908A2 (en) 2007-11-28
EP1858908A4 (en) 2010-01-27
US7368422B2 (en) 2008-05-06

Similar Documents

Publication Publication Date Title
US20080214444A1 (en) Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US20090131304A1 (en) Semi-Synthetic Desmethyl-Vancomycin-Based Glycopeptides With Antibiotic Activity
JP2009102446A (ja) 抗菌活性を有する半合成グリコペプチド
US20120129763A1 (en) Novel semi-synthetic glycopeptides as antibacterial agents
WO2011140009A1 (en) Methods of using semi-synthetic glycopeptides as antibacterial agents
GB2449156A (en) Semi-synthetic glycopeptides with antibacterial activity
US20100216699A1 (en) Semi-synthetic glycopeptides having antibacterial activity
US20110015119A1 (en) Novel semi-synthetic glycopeptides as antibacterial agents
US20120252741A1 (en) Novel semi-synthetic glycopeptides as antibacterial agents
EP1373289A1 (en) 9-amino-14-membered macrolide derived from leucomycin

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 21, NO 41, PAGE(S) 4720 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE -NAME INDEX UNDER THE NAME NORTH CHINA PHARMACEUTICAL GROUP CORPORATION AND NOVARTIS VACCINES AND DIAGNOSTIC INC., APPLICATION NO. 2006218743, UNDER INID (71), CORRECT THE NAME TO NORTH CHINA PHARMACEUTICAL GROUP CORPORATION AND NOVARTIS VACCINES AND DIAGNOSTICS INC.

PC1 Assignment before grant (sect. 113)

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS INC.

Free format text: FORMER APPLICANT(S): NORTH CHINA PHARMACEUTICAL GROUP CORPORATION; NOVARTIS VACCINES AND DIAGNOSTICS INC.

MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period